© BusinessWire
15.10.2024
ALM
LISTED
BME
Almirall Announces Completion of Decentralized Regulatory Approval Procedure for Efinaconazole in Europe
News Preview
Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful completion of the decentralized regulatory procedure in Europe for efinaconazole, a triazole antifungal compound indicated for the treatment of fungal infection of the nail, known as onychomycosis, under the trade name of Jublia®....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2024
ORNBV
LISTED
HEL
Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024
News Preview
ORION CORPORATION PRESS RELEASE 15 OCTOBER 2024 at 9.00 EEST...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2024
DBV
LISTED
EURONEXT
Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
News Preview
Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
14.10.2024
AGFB
LISTED
EURONEXT
Publication of a transparency notification – Regulated information
News Preview
...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
14.10.2024
CU6
LISTED
ASX
Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer
News Preview
Highlights
United States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for 64Cu-SAR-bisPSMA diagnostic in prostate cancer patients with biochemical recurrence (BCR), AMPLIFY.The positive results of the completed COBRA and PROPELLER trials, including the significantly higher uptake and retention in...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.10.2024
GXI
LISTED
XETR
Solarstrom für Gerresheimer Standort in Momignies, Belgien
News Preview
Solarstrom für Gerresheimer Standort in Momignies, Belgien
2,3 MWp Photovoltaik-Dachanlage auf Produktionsgebäude
Gerresheimer baut Ökostromanteil bei Energieversorgung aus
Ziel bis 2030: 100 % Strom aus erneuerbaren Quellen
Düsseldorf/ Momignies, 14. Oktober 2024. Gerresheimer, innovativer System- und Lösungsanbieter und globaler Partner für di......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.10.2024
GXI
LISTED
XETR
Solar power for Gerresheimer site in Momignies, Belgium
News Preview
Solar power for Gerresheimer site in Momignies, Belgium
2.3 MWp rooftop photovoltaic system on production building
Gerresheimer increases share of green electricity in its energy supply
Goal for 2030: 100% electricity from renewable sources
Duesseldorf/Momignies, October 14, 2024. Gerresheimer, an innovative system and solution partner and a glo......
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2024
ORNBV
LISTED
HEL
Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU
News Preview
ORION CORPORATION INVESTOR NEWS 14 OCTOBER 2024 at 11.00 EEST...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2024
AGFB
LISTED
EURONEXT
Fiona Lam appointed as CFO for the Agfa-Gevaert Group - Regulated information - Contains inside information
News Preview
...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2024
RAY B
LISTED
STO
RaySearch has more than 100 RayStation customers in China
News Preview
STOCKHOLM, Oct. 11, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that the number of radiotherapy centers in China using RayStation®* for treatment planning now has passed 100. In terms of number of centers, China is RaySearch's third largest market after the US and Japan.
Since its launch in 2009, RayStation has bee...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.10.2024
CHEMM
LISTED
CPH
ChemoMetec’s potential acquisition of Ovizio Imaging Systems SA
News Preview
ANNOUNCEMENT NO. 278...
Themefolio
Profiler
Peergroup
© Newsfile
11.10.2024
COPN
LISTED
SIX
Cosmo Pharmaceuticals Appoints New Chief Financial Officer
News Preview
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - October 11, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is delighted to announce the appointment of Svetlana Sigalova as its new Chief Financial Officer, effective November 11, 2024. Svetlana will succeed Niall D...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
10.10.2024
EAPI
LISTED
EURONEXT
EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution
News Preview
“The completion of the financing is an instrumental step in the execution of EUROAPI’s strategic roadmap” said Ludwig de Mot, Chief Executive Officer. “Combined with further developments in our commercial relationship with Sanofi, it opens a new chapter for our company and all its stakeholders.”...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2024
ERF
LISTED
EURONEXT
Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration
News Preview
Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, announced today the renewal of its collaboration with Italy-based Dompé farmaceutici S.p.A., which is applying their internal AI platform to accelerate the identification of novel therapeutics.
This collaboration moves into a second year as a re...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
INDV
LISTED
NASDAQ
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
News Preview
Conference Call Today at 8:00 AM US Eastern
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018).
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
INDV
LISTED
NASDAQ
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
News Preview
Conference Call Today at 8:00 AM US Eastern
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018).
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
VITR
LISTED
STO
Conference call interim report
News Preview
GOTHENBURG, Sweden, Oct. 10, 2024 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q3, 2024. The presentation will be held in English.
Time: Thursday 24 October, 2024 at 10.00 a.m. CET.
To attend the conference call, please use this link to register. After registration, you wil...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
RAY B
LISTED
STO
GenesisCare UK selects RayStation
News Preview
STOCKHOLM, Oct. 10, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that GenesisCare UK has placed an order for the RayStation®* treatment planning system.
GenesisCare is the UK's leading independent cancer care provider, operating 14 specialist outpatient cancer centers. This order signifies the plan to fully replac...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2024
FAGR
LISTED
EURONEXT
Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 October 2024 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2024
SLP
LISTED
NASDAQ
Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report fourth quarter and fiscal 2024 financial results after the market close on Wednesday, October 23, 2024.
Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and p...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2024
AFX
LISTED
XETR
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions
News Preview
Showcasing at AAO 2024:
ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline clinic operations.ZEISS Milestone: Celebrating more than 10 million eyes treated with lenticule extraction solutions utilizing ZEISS SMILE and ZEISS SMILE pro.ZEISS marked its 25th year of leadersh...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2024
HLN
LISTED
LSE
Haleon Canada Donates Children's Advil to Organizations in Need
News Preview
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most.
MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian-based, non-profit organizations. This donation supports Ha...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2024
SOBI
LISTED
STO
Invitation: Sobi's Q3 2024 report
News Preview
STOCKHOLM, Oct. 9, 2024 /PRNewswire/ --
Sobi plans to publish its report for the third quarter of 2024 on 24 October 2024 at 08:00 CEST.
Investors, analysts, and the media are invited to a conference call on the same day at 14:00 CEST, 13:00 BST, and 08:00 EDT. The call will include a presentation of the results and a Q&A session.
The presen...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2024
ZLAB
LISTED
NASDAQ
Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688; “Zai Lab”) today announced that data from a Phase 1 study of ZL-1310, the Company’s investigational antibody-drug conjugate (ADC), will be presented during a plenary session at the EORTC-NCI-AACR Symposium (ENA) 2024 taking place October 23-25, in Barcelona, Spain. The preliminary results from the ongoing...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2024
SN
LISTED
LSE
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
News Preview
Patented technology further personalizes total knee arthroplasty for surgeons and patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2024
ZEAL
LISTED
CPH
Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
News Preview
Company announcement – No. 48 / 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2024
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Announces Date of 2024 Third Quarter Earnings Call
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the s...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2024
AMRX
LISTED
NASDAQ
Amneal to Report Third Quarter 2024 Results on November 8, 2024
News Preview
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time.
The financial results and live webcast will be acces...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2024
LIVN
LISTED
NASDAQ
LivaNova Appoints Susan Podlogar as a New Director
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its Board of Directors has appointed Susan Podlogar to the Board, effective today. Podlogar will serve on the Compensation and Human Capital Management Committee for the Board.
“LivaNova’s Board of Directors is pleased to welcome Susan Podlogar,” said William Kozy...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2024
SLP
LISTED
NASDAQ
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced the award of a new research grant from the National Institutes of Health (NIH), secured in partnership with the University o...
Themefolio
Profiler
Peergroup
© EQS Newswire
08.10.2024
EUZ
LISTED
XETR
Eckert & Ziegler und GlyTherix unterzeichnen Vertrag zur Lieferung von Lutetium-177
News Preview
Berlin, Deutschland und Sydney, Australien - 08. Oktober 2024 - Eckert & Ziegler (ISIN DE0005659700, SDAX) und GlyTherix Ltd (GlyTherix), ein australisches Unternehmen aus dem Bereich der zielgerichteten Strahlentherapie, das sich auf die Entwicklung von Antikörper-Radiopharmaka zur Behandlung von soliden Tumoren spezialisiert hat, gaben heute ......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.10.2024
EUZ
LISTED
XETR
Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
News Preview
Berlin, Germany and Sydney, Australia - 08. October 2024 - Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today announced a new global clinical supply agreement. Eckert & Ziegler will provide its......
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2024
ZEAL
LISTED
CPH
Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide
News Preview
Company announcement – No. 47 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2024
QGEN
LISTED
NYSE
Global TB Summit 2024: QIAGEN an vorderster Front im Kampf gegen Tuberkulose, eine der tödlichsten Infektionskrankheiten
News Preview
QIAGENs führender Tuberkulose-Bluttest QuantiFERON®-TB Gold Plus für den Nachweis latenter Tuberkulose-Infektionen trägt weiterhin dazu bei, den Kreislauf der Krankheitsübertragung zu durchbrechen // Mehr als 35 hochkarätige Tuberkulose-Experten diskutieren über wichtige Themen wie Fortschritte in der Diagnostik und neue Behandlungsstrategien // CP...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
INDV
LISTED
NASDAQ
Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review
News Preview
PDUFA date set for February 7, 2025If approved by the FDA, label would expand to include alternative injection sites in the thigh, buttock and back of the arm for induction and maintenance as well as rapid induction one hour after a single transmucosal buprenorphine dose; both of which address significant patient and healthcare provider unmet nee...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
ALK B
LISTED
CPH
ALK Announces U.S. FDA Approval of New AccuTest™ Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis
News Preview
– The innovative AccuTest™ features a range of single prick and multi-head skin testing devices and well trays to improve the accuracy of allergy diagnosis and testing –
BEDMINSTER, N.J., Oct. 7, 2024 /PRNewswire/ -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the prevention, d...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
CYRX
LISTED
NASDAQ
Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus
News Preview
The IntegriCell Platform Will Deliver High-Quality Cryopreservation Services for Cell-Based Therapies
NASHVILLE, Tenn., Oct. 7, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of its IntegriCell™ cryopreservation services...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2024
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024
News Preview
MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2024
MURA
LISTED
NASDAQ
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
News Preview
WALTHAM, Mass and DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced three upcoming poster presentations at the 39th Annu...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
IMMNOV
LISTED
STO
Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
News Preview
LUND, Sweden, Oct. 7, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer. Concluding the sample collection effort marks a key milestone toward successfull...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
IMMNOV
LISTED
STO
Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
News Preview
LUND, Sweden, Oct. 7, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer. Concluding the sample collection effort marks a key milestone toward successfull...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
HNSA
LISTED
STO
Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
News Preview
LUND, Sweden, Oct. 7, 2024 /PRNewswire/ -- Hansa Biopharma AB, ("Hansa" or the "Company") (NASDAQ STOCKHOLM: HNSA), today announced positive results from a 12-month follow up analysis from the NICE-01 trial of HNSA-5487, the Company's next generation immunoglobulin G (IgG)-cleaving molecule, assessing IgG recovery, immunogenicity and redosing pot...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2024
HNSA
LISTED
STO
Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
News Preview
LUND, Sweden, Oct. 7, 2024 /PRNewswire/ -- Hansa Biopharma AB, ("Hansa" or the "Company") (NASDAQ STOCKHOLM: HNSA), today announced positive results from a 12-month follow up analysis from the NICE-01 trial of HNSA-5487, the Company's next generation immunoglobulin G (IgG)-cleaving molecule, assessing IgG recovery, immunogenicity and redosing pot...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2024
GLPG
LISTED
EURONEXT
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
News Preview
Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the appointment by way of co-optation of Oleg Nodelman as Non-Executive Non-Independent Director to its Board of Directors, effective October 7, 2024....
Themefolio
Profiler
Peergroup
© BusinessWire
04.10.2024
BLUE
LISTED
NASDAQ
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement awards of 242,500 restricted stock units (RSUs). This includes the previously disclosed 100,000 RSUs granted to the Company’s CFO, James Sterling, with a grant date of September 30, 2024 and 142,500...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.10.2024
GMAB
LISTED
CPH
Major Shareholder Announcement
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2024
VITR
LISTED
STO
Election committee for Vitrolife AB (publ)
News Preview
GOTHENBURG, Sweden, Oct. 4, 2024 /PRNewswire/ --
The following people have been appointed as members of the election committee for Vitrolife AB for the Annual General Meeting in 2025:
Niels Jacobsen, appointed by William Demant Invest A/SPatrik Tigerschiöld, appointed by Bure Equity ABPatricia Hedelius, appointed by AMF Fonder & PensionJón...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.10.2024
REC
LISTED
EURONEXT
レコルダティ、エジャイモ®のグローバル権利取得に合意し、希少疾患事業を強化
News Preview
レコルダティ、エジャイモ®のグローバル権利取得に合意し、希少疾患事業を強化...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2024
ORX
LISTED
STO
Orexo´s Nomination Committee for the Annual General Meeting 2025
News Preview
UPPSALA, Sweden, Oct. 4, 2024 /PRNewswire/ -- The members of the Nomination Committee for the Annual General Meeting (AGM), that takes place on May 8, 2025, have been appointed and comprises of the following members:
Henrik Kjaer Hansen, (Chairman, appointed by Novo Holdings A/S)Claus Berner Møller, (appointed by The Danish Labour Market Supplem...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2024
ORX
LISTED
STO
Orexo´s Nomination Committee for the Annual General Meeting 2025
News Preview
UPPSALA, Sweden, Oct. 4, 2024 /PRNewswire/ -- The members of the Nomination Committee for the Annual General Meeting (AGM), that takes place on May 8, 2025, have been appointed and comprises of the following members:
Henrik Kjaer Hansen, (Chairman, appointed by Novo Holdings A/S)Claus Berner Møller, (appointed by The Danish Labour Market Supplem...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.10.2024
REC
LISTED
EURONEXT
RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE
News Preview
Milan, 4th October 2024 – Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold agglutinin disease (CAD), a rare B-cell lymphoproliferative disorder....
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2024
HELP
LISTED
NASDAQ
Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in the Water...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2024
IBAB
LISTED
EURONEXT
IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain
News Preview
A EUR 16 million Initiative to Establish Strategic EU Autonomy in Alpha Therapies for Cancer...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2024
MURA
LISTED
NASDAQ
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
WALTHAM, Mass. and DUBLIN, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on October 1, the Company granted to three new...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2024
AMP
LISTED
EURONEXT
Amplifon Named One of the 200 “America’s Most Loved Workplaces” by Newsweek
News Preview
Amplifon, parent company of Miracle-Ear and the world leader in hearing care services and solutions, has been included in Newsweek's annual ranking of America's 200 Most Loved Workplaces®.
The ranking, developed by Newsweek in partnership with Most Loved Workplaces® and the Best Practice Institute (BPI), lists the companies that employees love th...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2024
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
al...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2024
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference
News Preview
CONSHOHOCKEN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced the company will participate in a fireside chat at the H.C. Wainwright 8th Annual MASH Virtual Investor Conference at 2:00 P.M. ET on Monday, Oct. 7, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2024
RXRX
LISTED
NASDAQ
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
News Preview
SALT LAKE CITY, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase 1/2 clinical trial of REC-1245, a new chemical...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
